Clinical Trial Update: Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy of N-acetylcysteine for bipolar disorder and tobacco use disorder. The current registry status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Tobacco Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Universidade Estadual de Maringá | Conditions: Bipolar Disorder | Phase 4 | Status: UNKNOWN